| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |